Jennifer Lord‐Bessen
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers 6
- CAR-T cell therapy research 5
- Applied Psychology top 10%
-
- Hemoglobinopathies and Related Disorders 8
- Myeloproliferative Neoplasms: Diagnosis and Treatment 4
-
- Acute Myeloid Leukemia Research 6
- Chronic Myeloid Leukemia Treatments 3
-
- Protein Degradation and Inhibitors 3
- Melanoma and MAPK Pathways 3
- Co-authors
- Allison J. ApplebaumHayley PessinEmma SteinBarry RosenfeldWilliam BreitbartLaurent MortierDirk SchadendorfPiotr Rutkowski
- Cited by
- OncologyApplied PsychologyGenetics
- Partner nations
- United StatesItalyFrance
In The Last Decade
Jennifer Lord‐Bessen
24 papers receiving 560 citations
Peers
Comparison fields: 5 of 82
- Oncology 368
- Applied Psychology 63
- Genetics 60
- Hematology 59
- Immunology 99
Countries citing papers authored by Jennifer Lord‐Bessen
This map shows the geographic impact of Jennifer Lord‐Bessen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jennifer Lord‐Bessen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jennifer Lord‐Bessen more than expected).
Fields of papers citing papers by Jennifer Lord‐Bessen
This network shows the impact of papers produced by Jennifer Lord‐Bessen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jennifer Lord‐Bessen. The network helps show where Jennifer Lord‐Bessen may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jennifer Lord‐Bessen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2024 | 0 | |
| 4 | 2024 | 1 | |
| 5 | 2024 | 1 | |
| 6 | 2023 | 9 | |
| 7 | 2023 | 4 | |
| 8 | 2023 | 9 | |
| 9 | 2023 | 2 | |
| 10 | 2023 | 6 | |
| 11 | 2022 | 0 | |
| 12 | 2022 | 2 | |
| 13 | 2021 | 12 | |
| 14 | 2021 | 3 | |
| 15 | 2021 | 13 | |
| 16 | 2021 | 8 | |
| 17 | 2019 | 2 | |
| 18 | 2014 | 4 | |
| 19 | 2013 | 44 | |
| 20 | 2013 | 157 |
About Jennifer Lord‐Bessen
Jennifer Lord‐Bessen is a scholar working on Hematology, Genetics and Oncology, having authored 29 papers that have together received 574 indexed citations. Recurring topics across this work include Hemoglobinopathies and Related Disorders (8 papers), Acute Myeloid Leukemia Research (6 papers), Cancer Immunotherapy and Biomarkers (6 papers), CAR-T cell therapy research (5 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (4 papers), Protein Degradation and Inhibitors (3 papers), Melanoma and MAPK Pathways (3 papers) and Chronic Myeloid Leukemia Treatments (3 papers). The work is most often cited by research in Oncology (368 citations), Applied Psychology (63 citations) and Genetics (60 citations). Jennifer Lord‐Bessen has collaborated with scholars based in United States, Italy and France. Frequent co-authors include Allison J. Applebaum, Hayley Pessin, Emma Stein, Barry Rosenfeld, William Breitbart, Laurent Mortier, Dirk Schadendorf, Piotr Rutkowski, Michael Smylie and Caroline Robert. Their work appears in journals such as Journal of Clinical Oncology, Blood and Annals of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.